MedTrace Logo

POL and Access Intervention to Reduce HIV Stigma Among Service Providers in China

NCT01052415 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5400

Last updated 2024-03-18

No results posted yet for this study

Summary

In this project, UCLA's Center for Community Health (CCH) will develop an efficacious intervention trial integrating both individual and structural components to reduce HIV- related stigma among service providers in China and therefore benefit people living with HIV/AIDS (PLWHA).

The purpose of this study is to develop a feasible, practical and low cost intervention strategy that will prevent and/or reduce the negative effects of HIV-related stigma among health service providers in China.

This project will be conducted in two provinces and proceed in two phases. In Phase 1, confidential focus groups will take place with small samples of service providers and hospital administrators to finalize the intervention activities, and the investigators will also test and finalize the Audio Computer-Assisted Self-Interview (ACASI) assessment measures and implementation procedures with the same group of service providers. During Phase 1 a small sample of patients will anonymously test the paper-pencil baseline survey. Equal number of samples will be selected from two counties of each province. The findings from Phase 1 will be used to develop intervention, and revise assessment for Phase 2.

Conditions

  • HIV-related Stigma
  • Patient Satisfaction
  • Provider-patient Interaction

Interventions

BEHAVIORAL

Cognitive behavioral sessions

Behavioral: Cognitive-behavioral, small group format sessions delivered in Chinese to service providers and HIV patients.

Sponsors & Collaborators

Principal Investigators

  • Li Li, PhD · UCLA Semel Institute, Center for Community Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2010-12-31
Completion
2011-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01052415 on ClinicalTrials.gov